Patrick Forde, MD

Videos

The Case for Chemoimmunotherapy for Patients With PD-L1-High Non-Small Cell Lung Cancer in the First-Line Setting

09/26/2023

At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Patrick Forde, MD, Johns Hopkins, debated in favor of chemoimmunotherapy in PD-L1 high non-small cell lung cancer.

At the Great Debates & Updates...

09/26/2023

Oncology

Videos

The Case for Adjuvant Immunotherapy in Resectable Non-Small Cell Lung Cancer

09/26/2023

Patrick Forde , MD;

At the Great Debates & Updates in Lung Cancer meeting in New York, New York, Patrick Forde, MD, debated in favor of adjuvant immunotherapy in resectable non-small cell lung cancer.

At the Great Debates & Updates...

09/26/2023

Oncology